Biomarkers to guide therapy or surveillance for prostate cancer.

about

Elevated YKL40 is associated with advanced prostate cancer (PCa) and positively regulates invasion and migration of PCa cells

P2860

Q34052057-7AE126A3-9031-4FD1-B475-4BD0C5D9F4CE

P2860

Biomarkers to guide therapy or surveillance for prostate cancer.

Item

http://www.wikidata.org/entity/Q45810868

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Biomarkers to guide therapy or surveillance for prostate cancer.

@en

Biomarkers to guide therapy or surveillance for prostate cancer.

@nl

type

Item

label

Biomarkers to guide therapy or surveillance for prostate cancer.

@en

Biomarkers to guide therapy or surveillance for prostate cancer.

@nl

prefLabel

Biomarkers to guide therapy or surveillance for prostate cancer.

@en

Biomarkers to guide therapy or surveillance for prostate cancer.

@nl

P1476

Biomarkers to guide therapy or surveillance for prostate cancer.

@en

P2093

Deborah Citrin

http://www.w3.org/2001/XMLSchema#string

Kathryn Hudak

http://www.w3.org/2001/XMLSchema#string

Kevin A Camphausen

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2012

Contemporary risk profile of prostate cancer in the United States.

Improvement of a predictive model of castration-resistant prostate cancer: functional genetic variants in TGFβ1 signaling pathway modulation.

Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study.

Identification of SNPs associated with susceptibility for development of adverse reactions to radiotherapy

SLCO2B1 and SLCO1B3 may determine time to progression for patients receiving androgen deprivation therapy for prostate cancer

Tissue biomarkers for prostate cancer radiation therapy.

Radical prostatectomy versus observation for localized prostate cancer.

A single nucleotide polymorphism in inflammatory gene RNASEL predicts outcome after radiation therapy for localized prostate cancer.

Prognostic determinants in prostate cancer.

P304

827-829

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.2217/BMM.13.123

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24266815

http://www.w3.org/2001/XMLSchema#string

P932

6342274

http://www.w3.org/2001/XMLSchema#string

Biomarkers to guide therapy or surveillance for prostate cancer.

about

P2860

P2860

Biomarkers to guide therapy or surveillance for prostate cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932